These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4393836)

  • 41. [Biochemical and EEG studies of disorders with neurastheniform onset in chronic cerebral circulatory insufficiency of atheromatous origin].
    Popoviciu L; Grecu F
    Stud Cercet Neurol; 1967; 12(6):429-44. PubMed ID: 6082538
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of arteriosclerosis obliterans with pyridinolcarbamate].
    Atsumi T; Isokane N; Yamashita S; Sano T; Odakura T; Kurai A
    Nihon Naika Gakkai Zasshi; 1967 Sep; 56(9):983-92. PubMed ID: 5627161
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term management of symptoms of cerebral arteriosclerosis.
    Stern FH
    Geriatrics; 1971 Jul; 26(7):98-103. PubMed ID: 4253476
    [No Abstract]   [Full Text] [Related]  

  • 44. [The use of androstanazole in some neurasthenic syndromes or reactions].
    Barberini E
    Minerva Med; 1967 Oct; 58(79):3371-5. PubMed ID: 6061043
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of chronic mental patients.
    Miller JF
    Geriatrics; 1965 Oct; 20(10):789-96. PubMed ID: 5833654
    [No Abstract]   [Full Text] [Related]  

  • 46. [Sleep-profile of a 72-year-old depressive female patient. Depression and sleep disorders. Significance--causes--treatment].
    Fortschr Neurol Psychiatr; 1998 May; 66(5 Suppl Depression):1-4. PubMed ID: 9696996
    [No Abstract]   [Full Text] [Related]  

  • 47. [Preliminary observations on a phospholipid-cytochrome C complex in geriatric therapy].
    Curri SB; Ziliotto GR
    G Gerontol; 1966 Nov; 14(11):1053-70. PubMed ID: 5998259
    [No Abstract]   [Full Text] [Related]  

  • 48. [Heparin treatment of mental disorders caused by arteriosclerosis].
    Krzymińska E; Krzymiński S
    Psychiatr Pol; 1975; 9(6):653-4. PubMed ID: 1197496
    [No Abstract]   [Full Text] [Related]  

  • 49. [The structure of transient cerebal cirulatory disorders (according to the reports of neurologic hospitals)].
    Shmidt EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(12):1761-71. PubMed ID: 4782237
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cerebral vessel sclerosis: involution-depression].
    Schulte W
    Wien Klin Wochenschr; 1969 Aug; 81(31):561-3. PubMed ID: 5404552
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 52. [Subacute and chronic cerebrovascular disorders. Diagnostic and therapeutic aspects].
    Fischer B; Fischer U
    Fortschr Med; 1973 Mar; 91(9):369-73. PubMed ID: 4695450
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacotherapy of tension and anxiety.
    Lehmann HE; Ban TA
    Curr Psychiatr Ther; 1972; 12():70-80. PubMed ID: 4555859
    [No Abstract]   [Full Text] [Related]  

  • 54. [Phospholipids in the treatment of arteriosclerotic pathological mental deterioration (PMD)].
    Bernardi S; Fanzago A
    Minerva Med; 1966 Jul; 57(54):2461-4. PubMed ID: 5946882
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of cerebral arteriosclerosis with heparin electrophoresis].
    Man'kovskiĭ NB; Mints AIa; Kalmykova OG; Pavlikova RN
    Vrach Delo; 1974; 4():78-83. PubMed ID: 4831873
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the pharmacological effects of an association of haloperidol and isopropamide bromide].
    Fiume S
    Clin Ter; 1966 Oct; 39(2):161-6. PubMed ID: 5996918
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of cerebrolysin in patients with cerebral arteriosclerosis].
    Zhovnir IK; Brozhik NS; Krotiuk LN
    Vrach Delo; 1973 Nov; 11():109-11. PubMed ID: 4786906
    [No Abstract]   [Full Text] [Related]  

  • 58. Study of the effect of N-methyl carbamate on the electroencephalogram in cerebral arteriosclerosis.
    Mori A; Ishikawa Y; Mukoyama K
    Jpn Heart J; 1967 May; 8(3):234-41. PubMed ID: 5299490
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparative evaluation of two hypnotic agents in genral practice patients with insomnia.
    Rickels K; Rosenfeld H; Schneider B; Silverman HA; Wagner IG
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):293-7. PubMed ID: 4625800
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.